# Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine

> **NCT03115047** · PHASE3 · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 80 (actual)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** Dexmedetomidine Injection
- **DRUG:** Meperidine Injection

## Key facts

- **NCT ID:** NCT03115047
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-07
- **Primary completion:** 2020-08-19
- **Final completion:** 2020-08-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03115047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03115047, "Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03115047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*